arrow
K

Kazuaki Matsumoto

keio university
H指数:30
被引数:3,890

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of area under the concentration-time curve estimations between Practical Antimicrobial Therapeutic Drug Monitoring (PAT) versions 3 and 4 for vancomycin using two-point sampling

通过两点采样比较万古霉素实用抗菌治疗药物监测(PAT)第3版和第4版浓度-时间曲线下面积估算值

2026-07-010
PRE
Application of epithelial lining fluid drug concentrations to MICi-Based PK/ PD modeling of cefepime/nacubactam in a murine model of CPE pneumonia

上皮衬液药物浓度在cefepime/nacubactam针对CPE肺炎小鼠模型的MICi-Based PK/PD建模中的应用

2025-12-010
PRE
Evaluating the necessity of two-point sampling for vancomycin area under the curve in follow-up therapeutic drug monitoring

评估两点采样法在随访治疗药物监测中测定万古霉素曲线下面积的必要性

2025-10-010
PRE
Development and external validation of a population pharmacokinetic model and optimal Vancomycin dosing regimen for overweight and obese patients
2025-10-010
PRE
Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective study

万古霉素治疗低血清肌酐水平患者AUC向上偏离的风险分层:一项多中心回顾性研究

2025-06-010
PRE
Reply to Mitsuboshi, Enhancing result reliability by addressing potential confounding factors

回复Mitsuboshi,通过解决潜在的混杂因素来提高结果的可靠性

2025-02-060
OAAI
Treatment success prediction in patients with methicillin-resistant coagulase-negative staphylococci infections, using vancomycin AUC24/MIC ratio: a multicentre retrospective cohort study
2024-12-170
PRE
Identification of Patients Who Require Two-Point Blood Sampling for the Peak and Trough Values Rather Than One-Point Blood Sampling for the Trough Value for the Evaluation of AUC of Vancomycin Using Bayesian Estimation
2024-10-212
PRE